|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to insurance coverage for certain devices that facilitate |
|
insulin therapy and enhance glucose control in the treatment of |
|
diabetes. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Sections 1358.051(1) and (2), Insurance Code, |
|
are amended to read as follows: |
|
(1) "Diabetes equipment" means: |
|
(A) blood glucose monitors, including |
|
noninvasive glucose monitors and glucose monitors designed to be |
|
used by blind individuals; |
|
(B) insulin pumps and associated appurtenances; |
|
(C) insulin infusion devices and devices that |
|
facilitate insulin therapy and enhance glucose control; and |
|
(D) podiatric appliances for the prevention of |
|
complications associated with diabetes. |
|
(2) "Diabetes supplies" means: |
|
(A) test strips for blood glucose monitors; |
|
(B) visual reading and urine test strips; |
|
(C) lancets and lancet devices; |
|
(D) insulin and insulin analogs; |
|
(E) injection aids and devices that facilitate |
|
insulin therapy and enhance glucose control; |
|
(F) syringes; |
|
(G) prescriptive and nonprescriptive oral agents |
|
for controlling blood sugar levels; and |
|
(H) glucagon emergency kits. |
|
SECTION 2. This Act applies only to an insurance policy that |
|
is delivered, issued for delivery, or renewed on or after January 1, |
|
2010. A policy delivered, issued for delivery, or renewed before |
|
January 1, 2010, is governed by the law as it existed immediately |
|
before the effective date of this Act, and that law is continued in |
|
effect for that purpose. |
|
SECTION 3. This Act takes effect September 1, 2009. |